Showing results (211-220 of 259) with videos related to

Sort By:
Pageof 26
Journal of Hematology & Oncology|August 24, 2021
Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in ChinaJie Zha, Liyuan Fan, Shuhua Yi, et al.
Seminars in Hematology|May 17, 2025
Report of Consensus Panel 4 from the 12th International Workshop on Waldenström's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphomaAlessandra Tedeschi, Rebecca Auer, Francesco Autore, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphomaWei Liu, Wei Liu, Hesong Zou, et al.
Experimental Hematology & Oncology|October 16, 2023
Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignanciesYuqin Song, Shang-Ju Wu, Zhixiang Shen, et al.
Blood Advances|October 10, 2019
The impact of response kinetics for multiple myeloma in the era of novel agentsYuting Yan, Xuehan Mao, Jiahui Liu, et al.
British Journal of Haematology|May 16, 2023
Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients: A multi-centre studyLinghui Zhou, Weijun Fu, Shenghao Wu, et al.
Biomarker Research|February 7, 2023
Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter studyJie Zha, Qinwei Chen, Jingjing Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2024
Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström MacroglobulinemiaYuting Yan, Ying Yu, Wenjie Xiong, et al.
International Journal of Cancer|May 19, 2023
Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICEDongfeng Zeng, Yu Fang, Yue Fei, et al.
Haematologica|October 9, 2025
Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 studyGang An, Jie Jin, Zhen Cai, et al.
Pageof 26